Almost everyone at some point will be affected by cancer in their lifetime.
Find out how you can
make a difference…
What if we could find new ways to reduce the effects of cancer?
Ground breaking research and practices start with ideas. We help those ideas grow.
Cancer Research Trust NZ funds research projects for all cancers, across prevention, early detection, diagnosis, treatment and end of life care.
-
Innovation
Cancer Research Trust NZ is an accelerator for new ideas that will help reduce the impact of cancer on our families, friends and community.
-
Results
Research is proven to greatly improve the prevention, treatment and management of cancer.
-
Trust
All projects funded by the Trust are rigorously reviewed by a panel of experts before acceptance, to maximise the value of all donations.
-
Transparency
100% of every dollar donated goes towards cancer related projects and training.
-
Collaboration
We support researchers and health professionals across the cancer spectrum to improve the management of cancer in New Zealand.
-
Hope
Research helps save lives - now and tomorrow.
Cancer Research Trust New Zealand has funded over $15 million in research projects and professional development
Research is the best hope against cancer.
We are helping to get cancer on the run by supporting innovative research projects.
Tackling the enormous burden caused by cancer is one of the greatest challenges of our generation.
Post-Doctoral Fellow
Auckland Cancer Society Research Centre School of Medical Sciences, University of Auckland
Funding New Zealand’s
best minds in cancer innovation.
Big things can happen from small beginnings.
Cancer Research Trust NZ gives bold ideas about cancer a chance to grow, to help get cancer on the run.
Professor Rod Dunbar
School of Biological Sciences. University of Auckland
The work of Professor Rod Dunbar on immune therapy is changing the way we treat cancer and the way we think about cancer.
The project support by the Trust has been crucial in allowing us to examine human cancer tissue in new ways. By visualising what the immune cells are doing in the tissue - how they interact with other cells in the cancer tissue, and how they change during treatment – we hope to determine which kind of immune therapy is best for each patient.
Dr Bridget Robinson
Bridget is finding new ways to defeat breast cancer.
Funded by the Trust, Bridget and her colleagues are using an innovative approach to identify cancer stem cells and study hypoxia and angiogenic factors in 300 human breast tumours collected by the Cancer Society Tissue Bank. Correlation with pathology and follow-up for each patient will show which factors predict cancer behaviour and this could lead to new stem cell targeted therapy.
If there is a link it could lead to more sophisticated diagnoses and help tailor treatment specifically to patients’ needs.
Mary Schumacher
CEO Hospice NZ
Mary is developing new ideas for the care of those living with cancer.
Palliative Care is about helping all stages of a life-limiting illness which may result in the person dying; whether years, months, weeks or days away. Palliative Care is about care for the living, not just the dying.
People are most comfortable in their own surroundings, every effort is made to provide support locally, either in a person’s home, or in a hospice, rest home or hospital.
Through funding from the Trust, Hospice New Zealand has met the challenge of communicating new ideas and practices through the Palliative Care lecture series, enabling professionals to increase their knowled ge of palliative care issues. These are delivered by experts in the field and the Royal New Zealand College of General Practitioners has approved the series as part of a continuing education programme for GP’s.
Dr Mary Jane Sneyd
University of Otago epidemiologist
specialising in melanoma.
Mary developed a tool to enable an early detection plan for those at highest risk.
The Trust helped fund this breakthrough research that identifies New Zealanders that are most likely to develop melanoma. Based on this research, Mary developed a High-Risk Assessment Tool to help lower New Zealand’s very high rate of melanoma.
Currently, general practitioners complete most of NZ’s skin examinations, and now they have Dr Sneyd's High-Risk Assessment Tool to help them identify melanoma earlier and develop treatment plans.